Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.

Wang L, Liu Z, Fisher KW, Ren F, Lv J, Davidson DD, Baldridge LA, Du X, Cheng L.

Hum Pathol. 2018 Jan;71:20-29. doi: 10.1016/j.humpath.2017.07.014. Epub 2017 Aug 4.

PMID:
28782638
2.

TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract.

Wang X, Lopez-Beltran A, Osunkoya AO, Wang M, Zhang S, Davidson DD, Emerson RE, Williamson SR, Tan PH, Kaimakliotis HZ, Baldridge LA, MacLennan GT, Montironi R, Cheng L.

Future Oncol. 2017 Apr;13(8):705-714. doi: 10.2217/fon-2016-0414. Epub 2017 Jan 5.

PMID:
28052688
3.

Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer.

Wang L, Ren F, Wang Q, Baldridge LA, Monn MF, Fisher KW, Sheng W, Zhou X, Du X, Cheng L.

Mol Diagn Ther. 2016 Apr;20(2):175-81. doi: 10.1007/s40291-016-0188-1.

PMID:
26891728
4.

Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.

Tran T, Jones CL, Williamson SR, Eble JN, Grignon DJ, Zhang S, Wang M, Baldridge LA, Wang L, Montironi R, Scarpelli M, Tan PH, Simper NB, Comperat E, Cheng L.

Histopathology. 2016 May;68(6):850-7. doi: 10.1111/his.12840. Epub 2015 Oct 21.

PMID:
26310887
5.

Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.

Choi E, Williamson SR, Montironi R, Zhang S, Wang M, Eble JN, Grignon DJ, Lopez-Beltran A, Idrees MT, Baldridge LA, Scarpelli M, Jones CL, Wang L, MacLennan GT, Osunkoya AO, Cheng L.

Histopathology. 2015 Jul;67(1):20-38. doi: 10.1111/his.12619. Epub 2015 Jan 29.

PMID:
25406945
6.

Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma.

Wang L, Williamson SR, Zhang S, Huang J, Montironi R, Davison DD, Wang M, Yao JL, Lopez-Beltran A, Osunkoya AO, MacLennan GT, Baldridge LA, Du X, Cheng L.

Mol Carcinog. 2015 Sep;54(9):900-7. doi: 10.1002/mc.22162. Epub 2014 Apr 29.

PMID:
24777847
7.

Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.

Wang L, Williamson SR, Wang M, Davidson DD, Zhang S, Baldridge LA, Du X, Cheng L.

Mol Cancer. 2014 Feb 26;13:39. doi: 10.1186/1476-4598-13-39.

8.

Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion.

Cheng L, Davidson DD, Maclennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Baldridge LA, Zhang S.

Am J Surg Pathol. 2013 Oct;37(10):1550-4. doi: 10.1097/PAS.0b013e318294e9bc.

PMID:
23887154
9.

Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.

Schelling LA, Williamson SR, Zhang S, Yao JL, Wang M, Huang J, Montironi R, Lopez-Beltran A, Emerson RE, Idrees MT, Osunkoya AO, Man YG, Maclennan GT, Baldridge LA, Compérat E, Cheng L.

Hum Pathol. 2013 Oct;44(10):2227-33. doi: 10.1016/j.humpath.2013.05.005. Epub 2013 Jul 12.

PMID:
23850495
10.

Novel markers of squamous differentiation in the urinary bladder.

Huang W, Williamson SR, Rao Q, Lopez-Beltran A, Montironi R, Eble JN, Grignon DJ, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Hahn NM, Wang M, Koch MO, Cheng L.

Hum Pathol. 2013 Oct;44(10):1989-97. doi: 10.1016/j.humpath.2013.04.005. Epub 2013 Jun 24.

PMID:
23806524
11.

Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.

Williamson SR, Zhang S, Eble JN, Grignon DJ, Martignoni G, Brunelli M, Wang M, Gobbo S, Baldridge LA, Cheng L.

Am J Surg Pathol. 2013 Aug;37(8):1131-9. doi: 10.1097/PAS.0b013e318282dab8.

PMID:
23648463
12.

Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.

Rao Q, Williamson SR, Lopez-Beltran A, Montironi R, Huang W, Eble JN, Grignon DJ, Koch MO, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Cheng L.

Mod Pathol. 2013 May;26(5):725-32. doi: 10.1038/modpathol.2012.229. Epub 2013 Jan 25.

13.

Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice.

Sliva D, Loganathan J, Jiang J, Jedinak A, Lamb JG, Terry C, Baldridge LA, Adamec J, Sandusky GE, Dudhgaonkar S.

PLoS One. 2012;7(10):e47873. doi: 10.1371/journal.pone.0047873. Epub 2012 Oct 30.

14.

Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.

Williamson SR, Halat S, Eble JN, Grignon DJ, Lopez-Beltran A, Montironi R, Tan PH, Wang M, Zhang S, Maclennan GT, Baldridge LA, Cheng L.

Am J Surg Pathol. 2012 Oct;36(10):1425-33.

PMID:
22982885
15.

Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients.

Labarrere CA, Woods JR, Hardin JW, Campana GL, Ortiz MA, Jaeger BR, Baldridge LA, Pitts DE, Kirlin PC.

PLoS One. 2012;7(4):e36100. doi: 10.1371/journal.pone.0036100. Epub 2012 Apr 25.

16.

Ectopic prostatic tissue: histogenesis and histopathological characteristics.

Halat S, Eble JN, Grignon DJ, Lacy S, Montironi R, MacLennan GT, Lopez-Beltran A, Tan PH, Baldridge LA, Cheng L.

Histopathology. 2011 Apr;58(5):750-8. doi: 10.1111/j.1365-2559.2011.03799.x. Epub 2011 Mar 25.

PMID:
21438904
17.

Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features.

Williamson SR, Zhang S, Lopez-Beltran A, Shah RB, Montironi R, Tan PH, Wang M, Baldridge LA, MacLennan GT, Cheng L.

Am J Surg Pathol. 2011 Apr;35(4):474-83. doi: 10.1097/PAS.0b013e31820f709e.

PMID:
21383609
18.

Triterpenes from Ganoderma Lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK).

Thyagarajan A, Jedinak A, Nguyen H, Terry C, Baldridge LA, Jiang J, Sliva D.

Nutr Cancer. 2010;62(5):630-40. doi: 10.1080/01635580903532390.

PMID:
20574924
19.

Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate.

Hahn NM, Reckova M, Cheng L, Baldridge LA, Cummings OW, Sweeney CJ.

J Clin Oncol. 2009 Jan 20;27(3):460-3. doi: 10.1200/JCO.2008.19.9380. Epub 2008 Dec 8. No abstract available.

PMID:
19064958
20.

TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder.

Armstrong AB, Wang M, Eble JN, MacLennan GT, Montironi R, Tan PH, Lopez-Beltran A, Zhang S, Baldridge LA, Spartz H, Cheng L.

Mod Pathol. 2009 Jan;22(1):113-8. doi: 10.1038/modpathol.2008.176. Epub 2008 Nov 7.

21.

Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.

Wang X, MacLennan GT, Zhang S, Montironi R, Lopez-Beltran A, Tan PH, Foster S, Baldridge LA, Cheng L.

Hum Pathol. 2009 Feb;40(2):211-7. doi: 10.1016/j.humpath.2008.07.003. Epub 2008 Sep 16.

PMID:
18799188
22.

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial.

Matei D, Emerson RE, Schilder J, Menning N, Baldridge LA, Johnson CS, Breen T, McClean J, Stephens D, Whalen C, Sutton G.

Cancer. 2008 Aug 15;113(4):723-32. doi: 10.1002/cncr.23605.

23.

Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.

Marks RA, Zhang S, Montironi R, McCarthy RP, MacLennan GT, Lopez-Beltran A, Jiang Z, Zhou H, Zheng S, Davidson DD, Baldridge LA, Cheng L.

Prostate. 2008 Jun 15;68(9):919-23. doi: 10.1002/pros.20715.

PMID:
18409189
24.

Germ cell origin of testicular carcinoid tumors.

Abbosh PH, Zhang S, Maclennan GT, Montironi R, Lopez-Beltran A, Rank JP, Baldridge LA, Cheng L.

Clin Cancer Res. 2008 Mar 1;14(5):1393-6. doi: 10.1158/1078-0432.CCR-07-4146.

25.

Lymphatic vessel density in radical prostatectomy specimens.

Cheng L, Bishop E, Zhou H, Maclennan GT, Lopez-Beltran A, Zhang S, Badve S, Baldridge LA, Montironi R.

Hum Pathol. 2008 Apr;39(4):610-5. doi: 10.1016/j.humpath.2007.09.006. Epub 2008 Mar 4.

PMID:
18284936
26.

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.

Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH.

J Biol Chem. 2008 Feb 29;283(9):5866-75. Epub 2007 Dec 17.

27.

Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.

Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, Montironi R, Tan PH, Zheng S, Baldridge LA, Cheng L.

Am J Surg Pathol. 2007 Dec;31(12):1861-7.

PMID:
18043040
28.

Microvascular thrombosis and cardiac allograft vasculopathy in rat heart transplantation.

Labarrere CA, Ortiz MA, Ruzmetov N, Sosa MJ, Campana G, Terry C, Baldridge LA, Antonopoulos R, DiCarlo HL.

J Heart Lung Transplant. 2006 Oct;25(10):1213-22. Epub 2006 Sep 15.

PMID:
17045934
29.

Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.

Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb TJ, Baldridge LA, Heidler KM, Cummings OW, Fujisawa T, Blum JS, Brand DD, Wilkes DS.

Am J Transplant. 2006 Apr;6(4):724-35.

30.

Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

Matei D, Emerson RE, Lai YC, Baldridge LA, Rao J, Yiannoutsos C, Donner DD.

Oncogene. 2006 Mar 30;25(14):2060-9.

PMID:
16331269
31.

Elevated expression of angiogenin in prostate cancer and its precursors.

Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L.

Clin Cancer Res. 2005 Dec 1;11(23):8358-63.

32.

P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.

Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, Koch MO, Lin H, Baldridge LA, Tretiakova M, Cheng L.

Anticancer Res. 2005 May-Jun;25(3B):2001-4.

33.

Syncytiotrophoblast intercellular adhesion molecule-1 expression in placental villitis of unknown cause.

Labarrere CA, Ortiz MA, Sosa MJ, Campana GL, Wernicke M, Baldridge LA, Terry C, DiCarlo HL.

Am J Obstet Gynecol. 2005 Aug;193(2):483-8.

PMID:
16098874
34.

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.

Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L.

Hum Pathol. 2005 Jul;36(7):718-23.

PMID:
16084939
35.

Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.

Sever M, Jones TD, Roth LM, Karim FW, Zheng W, Michael H, Hattab EM, Emerson RE, Baldridge LA, Cheng L.

Mod Pathol. 2005 Nov;18(11):1411-6.

36.

Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi.

Humphreys TL, Baldridge LA, Billings SD, Campbell JJ, Spinola SM.

Infect Immun. 2005 Jul;73(7):3896-902.

37.

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.

Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang S, Pan CX, Baldridge LA.

Am J Pathol. 2005 May;166(5):1533-9.

38.

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Gardner T, Smith M, Nakshatri H, Cheng L.

Clin Cancer Res. 2004 Aug 15;10(16):5501-7.

39.

OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.

Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L.

Am J Surg Pathol. 2004 Jul;28(7):935-40.

PMID:
15223965
40.

Loss of 14-3-3sigma in prostate cancer and its precursors.

Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM, Eble JN.

Clin Cancer Res. 2004 May 1;10(9):3064-8.

41.

PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, Cheng L.

Clin Cancer Res. 2004 Feb 15;10(4):1333-7.

42.

High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.

Zeng G, Hu Z, Kinch MS, Pan CX, Flockhart DA, Kao C, Gardner TA, Zhang S, Li L, Baldridge LA, Koch MO, Ulbright TM, Eble JN, Cheng L.

Am J Pathol. 2003 Dec;163(6):2271-6.

43.

Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition.

Humphreys TL, Schnizlein-Bick CT, Katz BP, Baldridge LA, Hood AF, Hromas RA, Spinola SM.

J Immunol. 2002 Dec 1;169(11):6316-23.

44.

Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.

Sanchez KM, Sweeney CJ, Mass R, Koch MO, Eckert GJ, Geary WA, Baldridge LA, Zhang S, Eble JN, Cheng L.

Cancer. 2002 Oct 15;95(8):1650-5.

45.

Three-dimensional imaging of human skin and mucosa by two-photon laser scanning microscopy.

Malone JC, Hood AF, Conley T, Nürnberger J, Baldridge LA, Clendenon JL, Dunn KW, Phillips CL.

J Cutan Pathol. 2002 Sep;29(8):453-8.

PMID:
12207738

Supplemental Content

Loading ...
Support Center